Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma
Frontiers in Oncology · 16.11.2026 · 16
DOI: 10.3389/fonc.2026.2023937 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 16.11.2026. Verfasst von Xiu Long und 9 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Retinoblastoma (RB) is the most common intraocular malignancy in children, but the role of PANoptosis, an integrated programmed cell death pathway involving apoptosis, pyroptosis, and necroptosis, remains unclear.
Methods
Bulk transcriptomic datasets from the GEO database were analyzed to identify PANoptosis-related differentially expressed genes (DEGs) in RB. Machine-learning algorithms were applied to develop a diagnostic signature. Functional enrichment, immune infiltration, drug–gene interaction, and ceRNA analyses were performed. Single-cell RNA sequencing was used to characterize the cellular distribution and biological functions of PANoptosis-related genes. Paired RB and adjacent retinal tissues from five patients were collected for RT-qPCR and western blot validation.
Results
Twenty-two PANoptosis-related DEGs were identified, and an exploratory five-gene signature consisting of BAX, CRADD, CD14, LY96, and TICAM1 showed promising apparent diagnostic discrimination in RB. External expression and ROC analyses provided additional support, although the small control cohorts limit performance inference. Single-cell analysis suggested different cellular distributions: BAX was relatively broadly detected in cone precursor-like tumor populations, whereas CD14 and LY96 were enriched in the microglia/macrophage compartment. Preliminary validation in five paired clinical specimens showed increased BAX, CD14, LY96, and TICAM1 mRNA expression and reduced CRADD expression; BAX protein abundance was also increased.
Conclusions
The five-gene PANoptosis-related signature represents an exploratory molecular finding in RB. Its clinical diagnostic value and mechanistic or therapeutic relevance require validation in larger independent cohorts and functional experiments.
Zitieren
APA
Long, X., Jiang, J., Yao, Y., Zheng, X., Zhao, S., Jiang, H., Yang, M., Long, Q., Jiang, B., & Gu, H. (2026). Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.2023937
Vancouver
Long X, Jiang J, Yao Y, Zheng X, Zhao S, Jiang H, et al. Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.2023937
BibTeX
@article{Long2026,
author = {Long, Xiu and Jiang, Jun and Yao, Yucheng and Zheng, Xueer and Zhao, Su and Jiang, Hao and Yang, Mei and Long, Qiurong and Jiang, Bo and Gu, Hao},
title = {Integrated bulk and single-cell transcriptomics reveal PANoptosis-linked immune programs and potential therapeutic targets in retinoblastoma},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.2023937}
}
EUVIMED